INTERWEST VENTURE MANAGEMENT CO - Q1 2018 holdings

$237 Million is the total value of INTERWEST VENTURE MANAGEMENT CO's 11 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 0.0% .

 Value Shares↓ Weighting
TSRO  TESARO INC$115,522,000
-31.0%
2,021,7380.0%48.67%
-15.0%
GKOS  GLAUKOS CORP$31,396,000
+20.2%
1,018,3620.0%13.23%
+48.1%
MGNX  MACROGENICS INC$27,029,000
+32.4%
1,074,3160.0%11.39%
+63.1%
HAIR  RESTORATION ROBOTICS INC$20,907,000
+35.4%
3,355,7860.0%8.81%
+66.8%
EIGR  EIGER BIOPHARMACEUTICALS INC$15,756,000
-29.4%
1,599,5920.0%6.64%
-13.0%
OBLN  OBALON THERAPEUTICS INC$8,415,000
-48.1%
2,453,3380.0%3.54%
-36.1%
AGTC  APPLIED GENETIC TECHNOL CORP$5,605,000
+6.9%
1,455,9040.0%2.36%
+31.8%
CDTX  CIDARA THERAPEUTICS INC$5,427,000
-41.2%
1,356,8130.0%2.29%
-27.5%
IVTY  INVUITY INC$4,159,000
-37.9%
1,080,2720.0%1.75%
-23.5%
KALV  KALVISTA PHARMACEUTICALS INC$3,128,000
-2.8%
329,9420.0%1.32%
+19.8%
XENE  XENON PHARMACEUTICALS INC$23,0000.0%8,2930.0%0.01%
+25.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-04-05
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GLAUKOS CORP28Q3 202333.0%
EIGER BIOPHARMACEUTICALS INC24Q3 202217.7%
APPLIED GENETIC TECHNOL CORP24Q3 20226.7%
XENON PHARMACEUTICALS INC20Q3 20210.6%
CIDARA THERAPEUTICS INC19Q2 20214.5%
THE REALREAL18Q3 202362.6%
KALVISTA PHARMACEUTICALS INC17Q4 202010.8%
DARE BIOSCIENCE INC16Q3 20230.3%
MACROGENICS INC14Q1 202019.2%
PMV PHARMACEUTICALS INC13Q3 202367.5%

View INTERWEST VENTURE MANAGEMENT CO's complete holdings history.

Latest filings
TypeFiled
1442024-02-27
13F-HR2023-10-20
13F-HR2023-07-21
13F-HR2023-04-27
13F-HR2023-01-31
13F-HR2022-10-25
13F-HR2022-08-02
13F-HR2022-04-13
13F-HR2022-01-25
13F-HR2021-10-19

View INTERWEST VENTURE MANAGEMENT CO's complete filings history.

Compare quarters

Export INTERWEST VENTURE MANAGEMENT CO's holdings